SkyePharma PLC Company Profile (NASDAQ:SKYEY)

About SkyePharma PLC

SkyePharma PLC logoSkyepharma Ltd, formerly Skyepharma PLC, is a drug delivery company engaged in the development of oral and inhalation products. The Company operates as an independent developer of complex pharmaceutical products for global markets. Its principal activities are the generation and development of product and drug delivery technology concepts, involving the application of its inhalation and oral technologies. It operates through the segment of development and supply of pharmaceutical products. It is also involved in the supply of products to its marketing partners, as in the case for flutiform and over seven oral products manufactured in its Lyon Facility. It operates primarily for respiratory applications. Its inhalation products include Relvar Ellipta/Breo Ellipta, Anoro Ellipta and Incruse Ellipta. Its oral products include RAYOS/LODOTRA, Requip Once-a-day, Xatral/Uroxatral, Madopar DR/Prolopa, Sular, ZYFLO CR, Paxil CR, Diclofenacratiopharm Uno, Triglide and Coruno.

Industry, Sector and Symbol:
  • Sector: N/A
  • Industry: N/A
  • Sub-Industry: N/A
  • Exchange: NASDAQ
  • Symbol: SKYEY
  • CUSIP:
Key Metrics:
  • Previous Close: $6.28
  • 50 Day Moving Average: $6.62
  • 200 Day Moving Average: $6.01
  • 52-Week Range: $3.95 - $6.97
  • Trailing P/E Ratio: N/A
  • P/E Growth: 0.00
  • Market Cap: $N/A
Additional Links:

Analyst Ratings

Consensus Ratings for SkyePharma PLC (NASDAQ:SKYEY) (?)
Ratings Breakdown: No ratings tracked in the last 12 months.
Consensus Rating:N/A (Score: NaN)
Consensus Price Target: N/A

Analysts' Ratings History for SkyePharma PLC (NASDAQ:SKYEY)
No equities research coverage for this company has been tracked by


Earnings History for SkyePharma PLC (NASDAQ:SKYEY)
No earnings announcements for this company have been tracked by


Earnings Estimates for SkyePharma PLC (NASDAQ:SKYEY)
No earnings estimates for this company have been tracked by


Dividend History for SkyePharma PLC (NASDAQ:SKYEY)
No dividend announcements for this company have been tracked by

Insider Trades

Insider Trading History for SkyePharma PLC (NASDAQ:SKYEY)
No insider trades for this company have been tracked by


Latest Headlines for SkyePharma PLC (NASDAQ:SKYEY)
DateHeadline logoSkyePharma Plc : Neutral assessment on price but strong on fundamentals (NASDAQ:SKYEY) - June 2 at 4:18 PM logoSkyePharma Plc :SKYEY-US: Earnings Analysis: For the six months ended December 31, 2015 (NASDAQ:SKYEY) - March 21 at 2:35 PM logoSkyePharma Plc :SKYEY-US: Earnings Analysis: 2015 By the Numbers (NASDAQ:SKYEY) - March 21 at 11:59 AM logoMundipharma Appointed as Development and Marketing Partner for flutiform(R) in Mexico, Central and South America (NASDAQ:SKYEY) - January 28 at 2:25 AM logoSkyePharma Plc : Overvalued relative to peers, but may deserve another look (NASDAQ:SKYEY) - January 7 at 4:09 PM logoSkyePharma Plc – Value Analysis (US OTC:SKYEY) : October 28, 2015 (NASDAQ:SKYEY) - October 28 at 1:55 PM


SkyePharma PLC (NASDAQ:SKYEY) Chart for Tuesday, October, 25, 2016

Last Updated on 10/25/2016 by Staff